Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Moses Lee is active.

Publication


Featured researches published by Moses Lee.


Bioorganic & Medicinal Chemistry Letters | 1997

Synthesis of an aminopropyl analog of the experimental anticancer drug tallimustine, and activation of its 4-nitrobenzylcarbamoyl prodrug by nitroreductase and NADH

Moses Lee; Jacob E. Simpson; Shirley Woo; Crystal Kaenzig; Ebun Eno-Amooquaye; Philip J. Burke

Compound 1, an analog of tallimustine that contains an aminopropyl group at the C-terminus, and its 4-nitrobenzylcarbamoyl prodrug 2 have been prepared. Analog 1 binds preferentially to the minor groove of poly(dA-dT) over poly(dG-dC), and is cytotoxic against the growth of LS1747 and SW1116 human colon cancer cells, with IC50 values of 0.02 μM and 10.0 μM, respectively. The prodrug 2 is significantly less cytotoxic (2.3 and 22.9 μM, respectively) than the parent drug 1. However, in the presence of nitroreductase and NADH prodrug 2 is as active as compound 1.


Chemico-Biological Interactions | 1995

The effect of AT and GC sequence specific minor groove-binding agents on restriction endonuclease activity

S. M. Forrow; Moses Lee; Robert L. Souhami; John A. Hartley

The ability of the naturally occurring A/T specific DNA minor groove binders netropsin and diastamycin A and two synthetic G/C selective oligopeptide analogues (1 and 2), to interfere with the catalytic activity of restriction endonucleases has been investigated. Enzymes were chosen to have A/T rich (EcoRI, EcoRV) or G/C rich (BalI, NruI) recognition sequences. An agarose gel assay was used to measure the cleavage of 32P-labelled DNA and ligand-DNA binding data was obtained using methidium-propyl EDTA footprinting. Netropsin and distamycin bind at the recognition sites, and dose-dependently inhibited cleavage by, EcoRI and EcoRV, (EcoRI > EcoRV). They were also more effective at inhibiting the catalytic activity of BalI than either 1 or 2. NruI was inhibited by distamycin and 2, but not by netropsin or 1. DNA footprinting revealed that neither 1 or 2 bound to the BalI or NruI recognition sequences under the conditions used whereas netropsin and distamycin footprint at adjacent sites. 1 binds to two of the three recognition sequences for the enzyme Fnu4HI (GCNGC) in the fragment studied and was shown to inhibit DNA cleavage only at these two sites. 2 binds strongly to two GGGCTC sequences which are recognition sites for the enzyme BanII. In this case a pronounced stimulation of cleavage was observed in the presence of 2 over a wide dose range. The results indicate that enzyme inhibition does not necessarily result from simultaneous occupancy of a common site, or at nearby flanking sequences, and in some circumstances, a pronounced stimulation of enzyme cleavage can occur.


Bioorganic & Medicinal Chemistry | 1995

Novel cytotoxic DNA sequence and minor groove targeted photosensitizers: Conjugates of pyrene and netropsin analogues

John A. Hartley; Joanne Webber; Michael D. Wyatt; Natalie Bordenick; Moses Lee

The design, syntheses, photochemical and biological properties of conjugates of pyrene with pyrrole- (1) and imidazole-containing (2) analogues of netropsin are reported. The results of an ethidium displacement assay and circular dichroism (CD) titration studies show both compounds bind with a higher affinity to poly(dA-dT) than to poly(dG-dC). In addition they bind as strongly to T4 coliphage DNA as to calf thymus DNA suggesting the binding occurs in the minor groove. The quenching rate constants of the singlet excited states of agents 1 and 2 by molecular oxygen were found to be 8.5 x 10(9) M-1S-1 and 7.7 x 10(9) M-1S-1, suggesting the involvement of singlet oxygen. Both compounds showed some cytotoxicity to human chronic myeloid leukemia K562 cells in the dark. Upon irradiation the activities were significantly enhanced resulting in photoinduced dose modifications of 8 and 14 for 1 and 2, respectively under the conditions employed. Both agents were markedly more phototoxic than 1-pyrenebutyric acid 8. To address the mechanism of action of compounds 1 and 2 their photoactivated abilities to produce DNA strand breaks were measured. Both agents caused increased single strand breakage with increasing UV exposure. The concentrations (EC50) of 1 and 2 needed to cause 50% single-strand cleavage of pBR322 DNA upon UV-A activation were found to be 40 microM and 45 microM, respectively. In contrast, no DNA strand breaks were observed in the dark with either conjugate or with 8 following irradiation. DNA strand breaks were measured in drug treated K562 cells using alkaline elution.(ABSTRACT TRUNCATED AT 250 WORDS)


Biochemistry | 1995

Sequence specificity of alkylation for a series of nitrogen mustard-containing analogs of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity

Wyatt; Moses Lee; Bonnie J. Garbiras; Robert L. Souhami; John A. Hartley


Anti-cancer Drug Design | 1997

Alkylation specificity for a series of distamycin analogues that tether chlorambucil.

Wyatt; Moses Lee; John A. Hartley


Journal of Medicinal Chemistry | 1994

GC SEQUENCE-SPECIFIC RECOGNITION BY AN N-FORMAMIDO, C-TERMINUS-MODIFIED AND IMIDAZOLE-CONTAINING ANALOG OF NETROPSIN

Moses Lee; Christopher S. Preti; Emily Vinson; Michael D. Wyatt; John A. Hartley


Nucleic Acids Research | 1997

The sequence specificity of alkylation for a series of benzoic acid mustard and imidazole-containing distamycin analogues: the importance of local sequence conformation

Michael D. Wyatt; Moses Lee; John A. Hartley


Medicinal Chemistry Research | 1996

Novel platinum(II) derivatives of analogues of netropsin and distamycin: Synthesis, DNA binding and cytotoxic properties

Moses Lee; Jacob E. Simpson; A. J. Burns; Stanley Kupchinsky; Natalie Brooks; John A. Hartley; Lloyd R. Kelland


Drug Design and Discovery | 1995

Design, synthesis and biological evaluation of benzoic acid mustard derivatives of imidazole-containing and C-terminal carboxamide analogues of distamycin

John A. Hartley; Christopher S. Preti; Michael D. Wyatt; Moses Lee


Journal of Chemical Education | 1996

Determination of the Solution Conformation of 3'-Azido-3'-deoxythymidine-5'-monophosphate (AZTMP): An Advanced Chemistry and Biochemistry Project Using NMR and Molecular-Modeling Studies

Moses Lee

Collaboration


Dive into the Moses Lee's collaboration.

Top Co-Authors

Avatar

John A. Hartley

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge